PeopleBio, Inc. (KOSDAQ:304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,348.00
-79.00 (-5.54%)
At close: Apr 28, 2026
-51.86%
Market Cap 31.57B
Revenue (ttm) 2.85B
Net Income (ttm) -15.71B
Shares Out 23.42M
EPS (ttm) -722.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 232,040
Average Volume 1,619,128
Open 1,431.00
Previous Close 1,427.00
Day's Range 1,342.00 - 1,480.00
52-Week Range 600.00 - 3,020.00
Beta 0.00
RSI 61.34
Earnings Date Apr 3, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Employees 46
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2025, PeopleBio's revenue was 2.85 billion, an increase of 12.64% compared to the previous year's 2.53 billion. Losses were -15.71 billion, 44.0% more than in 2024.

Financial Statements

News

There is no news available yet.